EMA approves two new drugs for MS and spinal muscular atrophy

The European Medicines Agency has approved two new treatments for multiple sclerosis and spinal muscular atrophy.

Published 10sem1 sourceImportant

≈ 23sSpeed

The fact

These authorizations mark a therapeutic advance for two serious neuromuscular diseases affecting thousands of patients across Europe.

The medicines are expected to become available on the market over the coming months.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 8, 2026